142 related articles for article (PubMed ID: 33914443)
1. Elaborating the Physiological Role of YAP as a Glucose Metabolism Regulator:A Systematic Review.
Sanjaya A; Goenawan H; Setiawan I; Gunadi JW; Limyati Y; Lesmana R
Cell Physiol Biochem; 2021 Apr; 55(2):193-205. PubMed ID: 33914443
[TBL] [Abstract][Full Text] [Related]
2. The role of YAP/TAZ activity in cancer metabolic reprogramming.
Zhang X; Zhao H; Li Y; Xia D; Yang L; Ma Y; Li H
Mol Cancer; 2018 Sep; 17(1):134. PubMed ID: 30176928
[TBL] [Abstract][Full Text] [Related]
3. Aerobic glycolysis tunes YAP/TAZ transcriptional activity.
Enzo E; Santinon G; Pocaterra A; Aragona M; Bresolin S; Forcato M; Grifoni D; Pession A; Zanconato F; Guzzo G; Bicciato S; Dupont S
EMBO J; 2015 May; 34(10):1349-70. PubMed ID: 25796446
[TBL] [Abstract][Full Text] [Related]
4. LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism.
Zheng X; Han H; Liu GP; Ma YX; Pan RL; Sang LJ; Li RH; Yang LJ; Marks JR; Wang W; Lin A
EMBO J; 2017 Nov; 36(22):3325-3335. PubMed ID: 28963395
[TBL] [Abstract][Full Text] [Related]
5. Interplay between YAP/TAZ and Metabolism.
Koo JH; Guan KL
Cell Metab; 2018 Aug; 28(2):196-206. PubMed ID: 30089241
[TBL] [Abstract][Full Text] [Related]
6. Hippo pathway cooperates with ChREBP to regulate hepatic glucose utilization.
Shu ZP; Yi GW; Deng S; Huang K; Wang Y
Biochem Biophys Res Commun; 2020 Sep; 530(1):115-121. PubMed ID: 32828272
[TBL] [Abstract][Full Text] [Related]
7. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
8. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
9. Insulin suppresses transcriptional activity of yes-associated protein in insulin target cells.
Sayedyahossein S; Hedman AC; Sacks DB
Mol Biol Cell; 2020 Jan; 31(2):131-141. PubMed ID: 31693448
[TBL] [Abstract][Full Text] [Related]
10. Splice variant insertions in the C-terminus impairs YAP's transactivation domain.
Finch-Edmondson ML; Strauss RP; Clayton JS; Yeoh GC; Callus BA
Biochem Biophys Rep; 2016 Jul; 6():24-31. PubMed ID: 28018981
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Jang JW; Kim MK; Bae SC
Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
[TBL] [Abstract][Full Text] [Related]
12. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways.
Santinon G; Pocaterra A; Dupont S
Trends Cell Biol; 2016 Apr; 26(4):289-299. PubMed ID: 26750334
[TBL] [Abstract][Full Text] [Related]
13. Targeting YAP and Hippo signaling pathway in liver cancer.
Liu AM; Xu MZ; Chen J; Poon RT; Luk JM
Expert Opin Ther Targets; 2010 Aug; 14(8):855-68. PubMed ID: 20545481
[TBL] [Abstract][Full Text] [Related]
14. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
15. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
16. Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth.
Cox AG; Tsomides A; Yimlamai D; Hwang KL; Miesfeld J; Galli GG; Fowl BH; Fort M; Ma KY; Sullivan MR; Hosios AM; Snay E; Yuan M; Brown KK; Lien EC; Chhangawala S; Steinhauser ML; Asara JM; Houvras Y; Link B; Vander Heiden MG; Camargo FD; Goessling W
EMBO J; 2018 Nov; 37(22):. PubMed ID: 30348863
[TBL] [Abstract][Full Text] [Related]
17. Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing.
Setiawan I; Sanjaya A; Lesmana R; Yen PM; Goenawan H
J Physiol Biochem; 2021 Feb; 77(1):63-73. PubMed ID: 33495890
[TBL] [Abstract][Full Text] [Related]
18. Integration of Hippo-YAP Signaling with Metabolism.
Ibar C; Irvine KD
Dev Cell; 2020 Jul; 54(2):256-267. PubMed ID: 32693058
[TBL] [Abstract][Full Text] [Related]
19. F-actin dynamics regulates mammalian organ growth and cell fate maintenance.
Pocaterra A; Santinon G; Romani P; Brian I; Dimitracopoulos A; Ghisleni A; Carnicer-Lombarte A; Forcato M; Braghetta P; Montagner M; Galuppini F; Aragona M; Pennelli G; Bicciato S; Gauthier N; Franze K; Dupont S
J Hepatol; 2019 Jul; 71(1):130-142. PubMed ID: 30878582
[TBL] [Abstract][Full Text] [Related]
20. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D
Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
